We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Infusion of Anesthetics Controls Pain Following Lung Surgery

By HospiMedica International staff writers
Posted on 25 Nov 2010
A continuous infusion of local anesthetic just over the intercostal nerve substantially reduces pain and helps patients return to normal faster after thoracic surgery, claims a new study.

Researchers at the Washington Institute of Thoracic and Cardiovascular Surgery (Washington, DC, USA) reviewed the records of 300 thoracic surgery patients given subpleural infusions of 0.25% bupivicaine, at a rate of 2 cc per hour for 10 days. More...
The infusion procedure involved two 12.7-cm catheters placed in a sub-pleural tunnel created by the surgeon, covering intercostal spaces two through eight. The researchers assessed postoperative pain using a 0-10 point Likert pain scale, comparing the results with a historical control group.

The results showed that pain rankings in the infusion group averaged 5 on post-op day one, 3 on day 14, and 1 on day 30, compared to 7.7, 6.8, and 4, respectively, in the control group. The median length of hospital stay in the infusion group was 4 days, not substantially different from the 5-6 day stay in the control group. However, return to normal function was substantially reduced, as was narcotic use for pain control. The study was presented at the annual international scientific assembly of the American College of Chest Physicians (ACCP), held during November 2010 in Vancouver (Canada).

"Usually systemic narcotics and epidurals are used to control pain after thoracic surgery. The problem is, epidurals are cumbersome, they wear off, and patients have to be in the hospital while they're being used. And narcotics have so many side effects,” said lead author and study presenter Barbara Tempesta, R.N., M.S. "The surgeons saw such a difference with the continuous infusions that they didn't want to do a randomized study.”

Significantly, the researchers found that the incidence of post-thoracotomy pain syndrome over a follow-up period of about 4 years was less than 3%; historically, however, about half of all patients undergoing thoracic surgery end up with chronic pain, and about 30% of patients might still experience pain 4-5 years later.

Related Links:
Washington Institute of Thoracic and Cardiovascular Surgery


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.